Αn advanced test that transforms how families plan for healthy pregnancies for those with genetic conditions has been developed by the Cyprus Institute of Neurology & Genetics.
The test has upgraded methodologies for preimplantation genetic testing for monogenic disorders, namely genetic conditions caused by pathogenic variations in a single gene, including beta-thalassemia, sickle cell anaemia, cystic fibrosis and neurofibromatosis.
Following many years of research, the institute’s blood disorder genetics and
